Abstract Introduction: Living donor kidney transplantation is considered the ideal renal replacement therapy because it has a lower complication rate and allows an efficient response to the high demand for grafts in the healthcare system. Careful selection and adequate monitoring of donors is a key element in transplantation. Individuals at greater risk of developing kidney dysfunction after nephrectomy must be identified. Objective: To identify risk factors associated with a renal compensation rate (CR) below 70% 12 months after nephrectomy. Methods: This observational retrospective longitudinal study included living kidney donors followed up at the Lower Amazon Regional Hospital between 2016 and 2022. Data related to sociodemographic variables, comorbid conditions and kidney function parameters were collected. Results: The study enrolled 32 patients. Fourteen (43.75%) had a CR < 70% 12 months after kidney donation. Logistic regression found obesity (Odds Ratio [95%CI]: 10.6 [1.7–65.2]), albuminuria (Odds Ratio [95%CI]: 2.41 [1.2–4.84]) and proteinuria (Odds Ratio [95%CI]: 1.14 [1.03–1.25]) as risk factors. Glomerular filtration rate was a protective factor (Odds Ratio [95% CI]: 0.92 [0.85–0.99]). Conclusion: Obesity, albuminuria and proteinuria adversely affected short-term renal compensation rate. Further studies are needed to uncover the prognostic implications tied to these risk factors. Our findings also supported the need for careful individualized assessment of potential donors and closer monitoring of individuals at higher risk. Introduction system identified Objective (CR 70 1 Methods 201 2022 variables collected Results 3 patients 43.75% 4375 43 75 (43.75% donation Odds 95%CI 95CI CI 95 [95%CI] 106 10 6 10. 1.7–65.2, 17652 1.7–65.2 , 7 65 2 [1.7–65.2]) 241 41 2.4 1.2–4.84 12484 4 84 [1.2–4.84] 114 14 1.1 1.03–1.25 103125 03 25 [1.03–1.25] 95% [95 CI] 092 0 92 0.9 0.85–0.99. 085099 0.85–0.99 . 85 99 [0.85–0.99]) Conclusion Obesity shortterm short term 20 202 43.75 437 (43.75 9 [95%CI 1765 1.7–65. [1.7–65.2] 24 2. 1.2–4.8 1248 8 [1.2–4.84 11 1. 1.03–1.2 10312 [1.03–1.25 [9 09 0. 08509 0.85–0.9 [0.85–0.99] 43.7 (43.7 176 1.7–65 [1.7–65.2 1.2–4. 124 [1.2–4.8 1.03–1. 1031 [1.03–1.2 [ 0850 0.85–0. [0.85–0.99 43. (43. 17 1.7–6 [1.7–65. 1.2–4 [1.2–4. 1.03–1 103 [1.03–1. 085 0.85–0 [0.85–0.9 (43 1.7– [1.7–65 1.2– [1.2–4 1.03– [1.03–1 08 0.85– [0.85–0. (4 1.7 [1.7–6 1.2 [1.2– 1.03 [1.03– 0.85 [0.85–0 ( [1.7– [1.2 1.0 [1.03 0.8 [0.85– [1.7 [1. [1.0 [0.85 [1 [0.8 [0. [0

Resumo Introdução: O transplante de rim de doador vivo é considerado a terapia renal substitutiva ideal por oferecer menor taxa de complicações e possibilitar uma resposta eficiente à grande demanda por enxertos no sistema de saúde. A seleção criteriosa e o acompanhamento adequado dos doadores constituem um pilar fundamental dessa modalidade terapêutica, sendo essencial a identificação dos indivíduos em maior risco de disfunção renal pós-nefrectomia. Objetivo: Identificar fatores de risco para uma Taxa de Compensação (TC) da função renal inferior a 70% 12 meses após a nefrectomia. Métodos: Estudo observacional, retrospectivo e longitudinal conduzido com doadores de rim vivo acompanhados no Hospital Regional do Baixo Amazonas entre 2016 e 2022. Foram coletados dados correspondentes a variáveis sociodemográficas, comorbidades e parâmetros de função renal. Resultados: Foram incluídos 32 pacientes na amostra final. Destes, 14 (43,75%) obtiveram TC < 70% 12 meses após a doação. A regressão logística identificou a obesidade (Odds Ratio [IC95%]: 10.6 [1.7–65.2]), albuminúria (Odds Ratio [IC95%]: 2.41 [1.2–4.84]) e proteinúria (Odds Ratio [IC95%]: 1.14 [1.03–1.25]) como fatores de risco. A taxa de filtração glomerular atuou como fator de proteção (Odds Ratio [IC95%]: 0.92 [0.85–0.99]). Conclusão: Obesidade, albuminúria e proteinúria demonstraram impacto negativo na taxa de compensação renal em curto prazo, o que reitera a necessidade de estudos acerca das implicações prognósticas desses fatores. Além disso, reforça-se a necessidade de avaliação cuidadosa e individualizada dos possíveis doadores, com acompanhamento rigoroso, especialmente para indivíduos de maior risco. Introdução saúde terapêutica pósnefrectomia. pósnefrectomia pós nefrectomia pós-nefrectomia Objetivo (TC 70 1 Métodos observacional 201 2022 sociodemográficas Resultados 3 final Destes 43,75% 4375 43 75 (43,75% doação Odds IC95% IC95 IC [IC95%] 106 10 6 10. 1.7–65.2, 17652 1.7–65.2 , 7 65 2 [1.7–65.2]) 241 41 2.4 1.2–4.84 12484 4 84 [1.2–4.84] 114 1.1 1.03–1.25 103125 03 25 [1.03–1.25] 092 0 92 0.9 0.85–0.99. 085099 0.85–0.99 . 85 99 [0.85–0.99]) Conclusão Obesidade prazo disso reforçase reforça se rigoroso 20 202 43,75 437 (43,75 IC9 [IC95% 1765 1.7–65. [1.7–65.2] 24 2. 1.2–4.8 1248 8 [1.2–4.84 11 1. 1.03–1.2 10312 [1.03–1.25 09 9 0. 08509 0.85–0.9 [0.85–0.99] 43,7 (43,7 [IC95 176 1.7–65 [1.7–65.2 1.2–4. 124 [1.2–4.8 1.03–1. 1031 [1.03–1.2 0850 0.85–0. [0.85–0.99 43, (43, [IC9 17 1.7–6 [1.7–65. 1.2–4 [1.2–4. 1.03–1 103 [1.03–1. 085 0.85–0 [0.85–0.9 (43 [IC 1.7– [1.7–65 1.2– [1.2–4 1.03– [1.03–1 08 0.85– [0.85–0. (4 1.7 [1.7–6 1.2 [1.2– 1.03 [1.03– 0.85 [0.85–0 ( [1.7– [1.2 1.0 [1.03 0.8 [0.85– [1.7 [1. [1.0 [0.85 [1 [0.8 [ [0. [0

Abstract Introduction: Living donor kidney transplantation is considered the ideal renal replacement therapy because it has a lower complication rate and allows an efficient response to the high demand for grafts in the healthcare system. Careful selection and adequate monitoring of donors is a key element in transplantation. Individuals at greater risk of developing kidney dysfunction after nephrectomy must be identified. Objective: To identify risk factors associated with a renal compensation rate (CR) below 70% 12 months after nephrectomy. Methods: This observational retrospective longitudinal study included living kidney donors followed up at the Lower Amazon Regional Hospital between 2016 and 2022. Data related to sociodemographic variables, comorbid conditions and kidney function parameters were collected. Results: The study enrolled 32 patients. Fourteen (43.75%) had a CR < 70% 12 months after kidney donation. Logistic regression found obesity (Odds Ratio [95%CI]: 10.6 [1.7–65.2]), albuminuria (Odds Ratio [95%CI]: 2.41 [1.2–4.84]) and proteinuria (Odds Ratio [95%CI]: 1.14 [1.03–1.25]) as risk factors. Glomerular filtration rate was a protective factor (Odds Ratio [95% CI]: 0.92 [0.85–0.99]). Conclusion: Obesity, albuminuria and proteinuria adversely affected short-term renal compensation rate. Further studies are needed to uncover the prognostic implications tied to these risk factors. Our findings also supported the need for careful individualized assessment of potential donors and closer monitoring of individuals at higher risk. Introduction system identified Objective (CR 70 1 Methods 201 2022 variables collected Results 3 patients 43.75% 4375 43 75 (43.75% donation Odds 95%CI 95CI CI 95 [95%CI] 106 10 6 10. 1.7–65.2, 17652 1.7–65.2 , 7 65 2 [1.7–65.2]) 241 41 2.4 1.2–4.84 12484 4 84 [1.2–4.84] 114 14 1.1 1.03–1.25 103125 03 25 [1.03–1.25] 95% [95 CI] 092 0 92 0.9 0.85–0.99. 085099 0.85–0.99 . 85 99 [0.85–0.99]) Conclusion Obesity shortterm short term 20 202 43.75 437 (43.75 9 [95%CI 1765 1.7–65. [1.7–65.2] 24 2. 1.2–4.8 1248 8 [1.2–4.84 11 1. 1.03–1.2 10312 [1.03–1.25 [9 09 0. 08509 0.85–0.9 [0.85–0.99] 43.7 (43.7 176 1.7–65 [1.7–65.2 1.2–4. 124 [1.2–4.8 1.03–1. 1031 [1.03–1.2 [ 0850 0.85–0. [0.85–0.99 43. (43. 17 1.7–6 [1.7–65. 1.2–4 [1.2–4. 1.03–1 103 [1.03–1. 085 0.85–0 [0.85–0.9 (43 1.7– [1.7–65 1.2– [1.2–4 1.03– [1.03–1 08 0.85– [0.85–0. (4 1.7 [1.7–6 1.2 [1.2– 1.03 [1.03– 0.85 [0.85–0 ( [1.7– [1.2 1.0 [1.03 0.8 [0.85– [1.7 [1. [1.0 [0.85 [1 [0.8 [0. [0

Resumo Introdução: O transplante de rim de doador vivo é considerado a terapia renal substitutiva ideal por oferecer menor taxa de complicações e possibilitar uma resposta eficiente à grande demanda por enxertos no sistema de saúde. A seleção criteriosa e o acompanhamento adequado dos doadores constituem um pilar fundamental dessa modalidade terapêutica, sendo essencial a identificação dos indivíduos em maior risco de disfunção renal pós-nefrectomia. Objetivo: Identificar fatores de risco para uma Taxa de Compensação (TC) da função renal inferior a 70% 12 meses após a nefrectomia. Métodos: Estudo observacional, retrospectivo e longitudinal conduzido com doadores de rim vivo acompanhados no Hospital Regional do Baixo Amazonas entre 2016 e 2022. Foram coletados dados correspondentes a variáveis sociodemográficas, comorbidades e parâmetros de função renal. Resultados: Foram incluídos 32 pacientes na amostra final. Destes, 14 (43,75%) obtiveram TC < 70% 12 meses após a doação. A regressão logística identificou a obesidade (Odds Ratio [IC95%]: 10.6 [1.7–65.2]), albuminúria (Odds Ratio [IC95%]: 2.41 [1.2–4.84]) e proteinúria (Odds Ratio [IC95%]: 1.14 [1.03–1.25]) como fatores de risco. A taxa de filtração glomerular atuou como fator de proteção (Odds Ratio [IC95%]: 0.92 [0.85–0.99]). Conclusão: Obesidade, albuminúria e proteinúria demonstraram impacto negativo na taxa de compensação renal em curto prazo, o que reitera a necessidade de estudos acerca das implicações prognósticas desses fatores. Além disso, reforça-se a necessidade de avaliação cuidadosa e individualizada dos possíveis doadores, com acompanhamento rigoroso, especialmente para indivíduos de maior risco. Introdução saúde terapêutica pósnefrectomia. pósnefrectomia pós nefrectomia pós-nefrectomia Objetivo (TC 70 1 Métodos observacional 201 2022 sociodemográficas Resultados 3 final Destes 43,75% 4375 43 75 (43,75% doação Odds IC95% IC95 IC [IC95%] 106 10 6 10. 1.7–65.2, 17652 1.7–65.2 , 7 65 2 [1.7–65.2]) 241 41 2.4 1.2–4.84 12484 4 84 [1.2–4.84] 114 1.1 1.03–1.25 103125 03 25 [1.03–1.25] 092 0 92 0.9 0.85–0.99. 085099 0.85–0.99 . 85 99 [0.85–0.99]) Conclusão Obesidade prazo disso reforçase reforça se rigoroso 20 202 43,75 437 (43,75 IC9 [IC95% 1765 1.7–65. [1.7–65.2] 24 2. 1.2–4.8 1248 8 [1.2–4.84 11 1. 1.03–1.2 10312 [1.03–1.25 09 9 0. 08509 0.85–0.9 [0.85–0.99] 43,7 (43,7 [IC95 176 1.7–65 [1.7–65.2 1.2–4. 124 [1.2–4.8 1.03–1. 1031 [1.03–1.2 0850 0.85–0. [0.85–0.99 43, (43, [IC9 17 1.7–6 [1.7–65. 1.2–4 [1.2–4. 1.03–1 103 [1.03–1. 085 0.85–0 [0.85–0.9 (43 [IC 1.7– [1.7–65 1.2– [1.2–4 1.03– [1.03–1 08 0.85– [0.85–0. (4 1.7 [1.7–6 1.2 [1.2– 1.03 [1.03– 0.85 [0.85–0 ( [1.7– [1.2 1.0 [1.03 0.8 [0.85– [1.7 [1. [1.0 [0.85 [1 [0.8 [ [0. [0

ABSTRACT Objective: To evaluate autoinflammatory diseases (AID) according to age at diagnosis and sex, and response to therapy in a large population. Methods: This is a cross-sectional observational study of a Latin American registry using a designed web system for data storage, collected between 2015 and 2018. Any altered findings during follow-up were recorded. The forms were translated into Portuguese and Spanish, including demographic, clinical, laboratory, genetic and treatment characteristics. Results: We included 152 patients, 51.3% male and 75% Caucasian. The median age at disease onset was 2.1 years (0–15.6 years) and median age at diagnosis 6.9 years (0–21.9 years); 111 (73%) were children (0–9 years old), and 41 (27%) were adolescents and young adults (AYA) (10–21 years old). Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome (PFAPA) occurred in 46/152 (30%), chronic non-bacterial osteomyelitis (CNO) in 32/152 (21%), and familial Mediterranean fever (FMF) in 24/152 (15.7%). PFAPA was significantly higher in young children than in AYA (38.7% vs. 7.3%, p<0.001), while CNO were lower (13.5% vs. 41.5%, p<0.001). The frequency of females was significantly higher in CNO (28.4% vs. 14.1%, p=0.031) and lower in FMF (8.1% vs. 23.1%, p=0.011). The most used drugs were glucocorticoids, non-steroidal anti-inflammatory drugs (NSAID), and colchicine. Glucocorticoids and colchicine treatment were used in all AID with good to moderate response. However, cryopyrin-associated periodic syndromes (CAPS) seemed unresponsive to glucocorticoids. NSAIDs and methotrexate were the main medications used to treat CNO. Conclusions: Differences among AID patients were observed in the LA population regarding sex and age at disease diagnosis. Objective (AID Methods crosssectional cross sectional storage 201 2018 followup follow up recorded Spanish demographic clinical laboratory characteristics Results 15 513 51 3 51.3 75 Caucasian 21 2 1 2. 0–15.6 0156 0 6 (0–15. 69 9 6. 0–21.9 0219 (0–21. 11 73% 73 (73% 0–9 09 (0– old, old , old) 4 27% 27 (27% (AYA 10–21 1021 10 (10–2 old. . stomatitis pharyngitis (PFAPA 46152 46 46/15 30%, 30 30% (30%) nonbacterial non bacterial (CNO 32152 32 32/15 21%, 21% (21%) (FMF 24152 24 24/15 15.7%. 157 15.7% 7 (15.7%) 38.7% 387 38 (38.7 vs 7.3% p<0.001, p0001 p p<0.001 001 p<0.001) 13.5% 135 13 5 (13.5 415 41.5% p<0.001. 28.4% 284 28 (28.4 141 14 14.1% p=0.031 p0031 031 8.1% 81 8 (8.1 231 23 23.1% p=0.011. p0011 p=0.011 011 p=0.011) glucocorticoids nonsteroidal steroidal antiinflammatory anti inflammatory NSAID, NSAID (NSAID) However cryopyrinassociated cryopyrin associated CAPS (CAPS Conclusions 20 51. 0–15. 015 (0–15 0–21. 021 (0–21 (73 0– (0 (27 10–2 102 (10– 4615 46/1 (30% 3215 32/1 (21% 2415 24/1 15.7 (15.7% 38.7 (38. 7.3 p000 p<0.00 00 13.5 (13. 41.5 28.4 (28. 14.1 p=0.03 p003 03 8.1 (8. 23.1 p001 p=0.01 01 (NSAID 0–15 (0–1 0–21 02 (0–2 (7 ( (2 10– (10 461 46/ (30 321 32/ (21 241 24/ 15. (15.7 38. (38 7. p00 p<0.0 13. (13 41. 28. (28 14. p=0.0 8. (8 23. 0–1 0–2 (1 (3 (15. p0 p<0. p=0. (15 p<0 p=0 p< p=

RESUMO Objetivo: Avaliar as doenças autoinflamatórias (DAI) de acordo com sexo e idade no momento do diagnóstico e a resposta terapêutica em uma grande população. Métodos: Este é um estudo observacional transversal de um registro latino-americano que usou um sistema de dados coletados entre 2015 e 2018. Quaisquer achados alterados ao longo do acompanhamento foram registrados. Os formulários foram traduzidos para os idiomas português e espanhol, incluindo características demográficas, clínicas, laboratoriais, genéticas e de tratamento. Resultados: Incluímos 152 pacientes, sendo 51,3% do sexo masculino e 75% da raça branca. A média de idade de início da doença foi de 2,1 anos (0–15,6 anos) e a média de idade de diagnóstico 6,9 anos (0–21,9 anos); 111 (73%) eram crianças (0–9 anos) e 41 (27%) adolescentes/adultos jovens (10–21 anos). A síndrome de febre periódica, estomatite aftosa, faringite e adenite (PFAPA) ocorreu em 46/152 (30%), osteomielite não bacteriana crônica (CNO) em 32/152 (21%) e febre familiar do Mediterrâneo (FMF) em 24/152 (15,7%). A PFAPA foi significativamente maior em crianças pequenas (38,7 vs. 7,3%, p<0,001), e a CNO, em adolescentes/adultos jovens (13,5 vs. 41,5%, p<0,001). A frequência do sexo feminino foi significativamente maior na CNO (28,4 vs. 14,1%, p=0,031) e menor na FMF (8,1 vs. 23,1%, p=0,011). Os medicamentos mais utilizados foram glicocorticoides, anti-inflamatórios não esteroidais (AINE) e colchicina. O tratamento com glicocorticoides e colchicina foi usado em todas as DAI com resposta boa a moderada. No entanto, as síndromes periódicas associadas à criopirina (CAPS) pareciam não responder aos glicocorticoides. AINE e metotrexato foram os principais medicamentos utilizados no tratamento da CNO. Conclusões: Diferenças de pacientes com DAI foram observadas na população latino-americana em pacientes agrupados por sexo e idade ao diagnóstico da doença. Objetivo (DAI Métodos latinoamericano latino americano 201 2018 registrados espanhol demográficas clínicas laboratoriais Resultados 15 513 51 3 51,3 75 branca 21 2 1 2, 0–15,6 0156 0 6 (0–15, 69 9 6, 0–21,9 0219 (0–21, 11 73% 73 (73% 0–9 09 (0– 4 27% 27 (27% adolescentesadultos adolescentes adultos 10–21 1021 10 (10–2 anos. . periódica aftosa (PFAPA 46152 46 46/15 30%, 30 30% , (30%) (CNO 32152 32 32/15 21% (21% (FMF 24152 24 24/15 15,7%. 157 15,7% 7 (15,7%) 38,7 387 38 (38, vs 7,3% p<0,001, p0001 p p<0,001 001 p<0,001) 13,5 135 13 5 (13, 415 41,5% p<0,001. 28,4 284 28 (28, 141 14 14,1% p=0,031 p0031 031 8,1 81 8 (8, 231 23 23,1% p=0,011. p0011 p=0,011 011 p=0,011) antiinflamatórios anti inflamatórios (AINE moderada entanto CAPS (CAPS Conclusões latinoamericana americana 20 51, 0–15, 015 (0–15 0–21, 021 (0–21 (73 0– (0 (27 10–2 102 (10– 4615 46/1 (30% 3215 32/1 (21 2415 24/1 15,7 (15,7% 38, (38 7,3 p000 p<0,00 00 13, (13 41,5 28, (28 14,1 p=0,03 p003 03 8, (8 23,1 p001 p=0,01 01 0–15 (0–1 0–21 02 (0–2 (7 ( (2 10– (10 461 46/ (30 321 32/ 241 24/ 15, (15,7 (3 7, p00 p<0,0 (1 41, 14, p=0,0 23, 0–1 0–2 (15, p0 p<0, p=0, (15 p<0 p=0 p< p=

Abstract Antimicrobial peptides (AMPs) are small groups of proteins obtained from plants and animals. AMPs participate in the immune response, as they provide a quick line of defense against infections, while others may be related to the plant's defense against certain pests and pathogens. The objective of the present study was to evaluate an inhibitory activity of fractions obtained from immature fruits of Capsicum chinense Jacq. (accession UENF 1755) on trypsin, chymotrypsin and α-amylase families and on yeast growth. The peptides were obtained from the immature fruits using saline extraction. The extract was semi-purified by DEAE-Sepharose chromatography into two fractions: D1 (non-retained fraction) and D2 (retained fraction), and analyzed using SDS-tricine-gel electrophoresis. The antifungal activity of these fractions was tested on Candida albicans, Candida buinensis, Candida parapsilosis and Candida tropicalis. To elucidate the antimicrobial mechanism of these fractions, membrane permeabilization and endogenous reactive oxygen species (ROS) induction assays were performed. The fractions were also tested for inhibition of trypsin, chymotrypsin and α-amylase enzymes. The two fractions, D1 and D2, inhibited yeast growth at a concentration of 100 μg.mL-1, promoted membrane permeabilization and caused an increase in the induction of endogenous ROS in C. albicans and C. tropicalis. Both these fractions were able to inhibit trypsin and α-amylase enzyme, while only D1 inhibited chymotrypsin activity. Thus, D1 was found to possess a greater antifungal and enzymatic inhibition activity on trypsin, chymotrypsin and α-amylase. (AMPs animals response infections plant s pathogens Jacq accession 1755 αamylase α amylase extraction semipurified semi purified DEAESepharose DEAE Sepharose D nonretained non retained fraction fraction, , SDStricinegel SDS tricine gel electrophoresis buinensis tropicalis (ROS performed enzymes 10 μg.mL1, μgmL1 μgmL μg.mL 1, μg mL 1 μg.mL-1 C enzyme Thus αamylase. amylase. 175 mL1 μg.mL1 μg.mL- 17

ABSTRACT BACKGROUND: The prevalence of chronic kidney disease (CKD) has increased in the recent decades, along with the number of patients in the terminal stages of this disease, requiring transplantation. Some skin disorders are more frequent in patients with CKD and in renal transplant recipients (RTR). OBJECTIVES: To evaluate the frequency of skin diseases in RTR and patients with CKD receiving conservative treatment. DESIGN AND SETTING: This observational cross-sectional study recruited consecutive patients with CKD and RTR from a nephrology clinic at a teaching hospital in Brazil between 2015 and 2020. METHODS: Quantitative, descriptive, and analytical approaches were used. The sample was selected based on convenience sampling. Data were collected from dermatological visits and participants’ medical records. RESULTS: Overall, 308 participants were included: 206 RTR (66.9%, median age: 48 years, interquartile range [IQR] 38.0–56.0, 63.6% men) and 102 patients with CKD (33.1%, median age: 61.0 years, IQR 50.0–71.2, 48% men). The frequency of infectious skin diseases (39.3% vs. 21.6% P = 0.002) were higher in RTR than in patients with CKD. Neoplastic skin lesions were present in nine (4.4%) RTR and in only one (1.0%) patient with CKD. Among the RTR, the ratio of basal cell carcinoma to squamous cell carcinoma was 2:1. CONCLUSIONS: This study revealed that an increased frequency of infectious skin diseases may be expected in patients who have undergone kidney transplantation. Among skin cancers, BCC is more frequently observed in RTR, especially in those using azathioprine. BACKGROUND (CKD decades transplantation RTR. . (RTR) OBJECTIVES treatment SETTING crosssectional cross sectional 201 2020 METHODS Quantitative descriptive used sampling records RESULTS Overall 30 included 20 66.9%, 669 66 9 (66.9% age 4 years [IQR 380560 38 0 56 38.0–56.0 636 63 6 63.6 men 10 33.1%, 331 33 1 (33.1% 610 61 61. 500712 50 71 2 50.0–71.2 men. 39.3% 393 39 3 (39.3 vs 216 21 21.6 0.002 0002 002 4.4% 44 (4.4% 1.0% (1.0% 21. 1. 2:1 CONCLUSIONS cancers azathioprine (RTR 202 66.9% (66.9 38056 5 38.0–56. 63. 33.1% (33.1 50071 7 50.0–71. 39.3 (39. 0.00 000 00 4.4 (4.4 1.0 (1.0 2: 66.9 (66. 3805 38.0–56 33.1 (33. 5007 50.0–71 39. (39 0.0 4. (4. (1. 66. (66 380 38.0–5 33. (33 500 50.0–7 (3 0. (4 (1 (6 38.0– 50.0– ( 38.0 50.0 38. 50.

Abstract This study investigated the correlation between socioeconomic factors and the COVID-19 pandemic in medium-sized Minas Gerais municipalities. Data were analyzed by partial least squares structural equation modeling, using the following variables: vulnerability, sanitation, income, aggravating factors, vaccination, COVID-19 cases, COVID-19 mortality, hospitalization and non-communicable chronic diseases. Data were obtained from the Minas Gerais Social Responsibility Index, the COVID-19 cases monitoring panel and the COVID-19 vaccination monitoring panel. Data collection time frame was determined by the onset of the pandemic and data availability (March 2020 to September 2021). Results showed that better sanitation conditions are negatively related to COVID-19 cases, income is positively related to COVID-19 cases, and higher mortality from chronic noncommunicable diseases are positively related to COVID-19 mortality. COVID-19 cases have a negative impact on hospitalization and hospitalization has a positive impact on mortality. Cases, moderated by vaccination, are negatively related to COVID-19 mortality. These findings confirm that less favorable socioeconomic conditions make society more vulnerable to COVID-19. COVID19 COVID 19 COVID-1 mediumsized medium sized municipalities modeling variables vulnerability non communicable Index March 202 2021. 2021 . 2021) Cases COVID19. 19. COVID1 1 COVID- 20 2

Resumo Este artigo objetivou verificar a relação entre os fatores socioeconômicos e a pandemia da covid-19 nos municípios de médio porte mineiros. O procedimento de análise de dados foi a modelagem de equações estruturais de mínimos quadrados parciais. As variáveis utilizadas foram vulnerabilidade, saneamento, renda, agravantes, vacinação, casos de covid-19, mortalidade por covid-19, hospitalização e doenças crônicas não transmissíveis. Os dados foram coletados no Índice Mineiro de Responsabilidade Social, no painel de monitoramento dos casos de covid-19 e no painel de monitoramento de vacinação contra covid-19. O recorte temporal foi determinado pelo início da pandemia e a disponibilidade de dados (março de 2020 a setembro de 2021). Os resultados evidenciaram que melhores condições de saneamento estão negativamente relacionadas aos casos de covid-19, a renda está positivamente relacionada com os casos de covid-19 e a taxa de mortalidade por doenças crônicas não transmissíveis está relacionada de forma positiva com a mortalidade por covid-19. Os casos de covid-19 têm impacto negativo na hospitalização e a hospitalização tem impacto positivo na mortalidade. Os casos moderados pela vacinação estão negativamente relacionados à mortalidade por covid-19. Os resultados confirmam que condições socioeconômicas menos favoráveis tornam a sociedade mais vulnerável a covid-19. covid19 covid 19 covid-1 mineiros parciais vulnerabilidade agravantes covid19, 19, Social covid19. 19. março 202 2021. 2021 . 2021) covid1 1 covid- 20 2

ABSTRACT Exacerbated inflammation and coagulation are a hallmark of COVID-19 severity. Extracellular vesicles (EVs) are intercellular transmitters involved in inflammatory conditions, which are capable of triggering prothrombotic mechanisms. Since the release of EVs is potentially associated with COVID-19-induced coagulopathy, the aim of this study was to evaluate changes in inflammation- and hypercoagulability-related EVs during the first month after symptom onset and to determine whether they are associated with disease severity. Blood samples of patients with mild or severe forms of the disease were collected on three occasions: in the second, third and fourth weeks after symptom onset for the quantification by flow cytometry of CD41A (platelet glycoprotein IIb/IIIa), CD162 (PSGL-1), CD31 (PECAM-1) and CD142 cells (tissue factor). Analysis of variance (ANOVA) with repeated measures, Kruskal-Wallis and correlation tests were used. Eighty-five patients were enrolled, 71% of whom had mild disease. Seventeen uninfected individuals served as controls. Compared to controls, both mild and severe COVID-19 were associated with higher EV-CD31+, EV-CD41+ and EV-CD142+ levels. All EV levels were higher in severe than in mild COVID-19 only after the third week from symptom onset, as opposed to C-reactive protein and D-dimer levels, which were higher in severe than in mild COVID-19 earlier during disease progression. EV levels were also associated with C-reactive protein and D-dimer levels only after the third week of symptoms. In conclusion, EVs expressing CD41A, CD31, TF, and CD162 appear as late markers of COVID-19 severity. This finding may contribute to the understanding of the pathogenesis of acute and possibly long COVID-19. COVID19 COVID 19 COVID-1 severity (EVs conditions mechanisms COVID19induced COVIDinduced induced coagulopathy hypercoagulabilityrelated hypercoagulability related occasions second CDA CD A platelet IIb/IIIa, IIbIIIa IIb/IIIa , IIb IIIa IIb/IIIa) CD16 PSGL1, PSGL1 PSGL 1 (PSGL-1) CD3 PECAM1 PECAM (PECAM-1 CD14 tissue factor. factor . factor) ANOVA (ANOVA measures KruskalWallis Kruskal Wallis used Eightyfive Eighty five enrolled 71 controls EVCD31+, EVCD31 EVCD CD31+, EV-CD31+ EVCD41+ EVCD41 CD41+ CD41 EV-CD41 EVCD142+ EVCD142 CD142+ EV-CD142 Creactive C reactive Ddimer D dimer progression symptoms conclusion TF COVID19. 19. COVID1 COVID- CD1 (PSGL-1 (PECAM- 7 EVCD31+ EVCD3 CD31+ EV-CD31 EVCD4 CD4 EV-CD4 EVCD14 EV-CD14 (PSGL- (PECAM EV-CD3 EV-CD EVCD1 EV-CD1 (PSGL

Abstract Objective To analyze intrinsic capacity and its ability to predict all-cause mortality in older adults living in a health microregion of Minas Gerais state, Brazil. Method A household survey study with a quantitative approach was conducted. Data were collected at homes using instruments validated for use in Brazil. Results Mean intrinsic capacity score was 5.8 (±1.63) points. During the follow-up period, with a mean follow-up time of 58.0 (±13.1) months, 142 deaths (16.4%) occurred. For each 1 point increase in intrinsic capacity score, there was a 21% reduction in the risk of mortality (p<0.001). Conclusion Intrinsic capacity served as a predictor of mortality in older adults. allcause all cause state Brazil conducted 58 5 8 5. ±1.63 163 63 (±1.63 points followup follow up period 580 0 58. ±13.1 131 13 (±13.1 months 14 16.4% 164 16 4 (16.4% occurred 21 p<0.001. p0001 p p<0.001 . 001 (p<0.001) ±1.6 6 (±1.6 ±13. (±13. 16.4 (16.4 2 p000 p<0.00 00 (p<0.001 ±1. (±1. ±13 (±13 16. (16. p00 p<0.0 (p<0.00 ±1 (±1 (16 p0 p<0. (p<0.0 ± (± (1 p<0 (p<0. ( p< (p<0 (p< (p

Resumo Objetivo Analisar a capacidade intrínseca e sua capacidade preditiva sobre a mortalidade por todas as causas em pessoas idosas residentes em uma microrregião de saúde de Minas Gerais, Brasil. Método Estudo tipo inquérito domiciliar, de abordagem quantitativa. Os dados foram coletados no domicílio com instrumentos validados no país. Resultados A média do escore de capacidade intrínseca foi de 5,8 (±1,63) pontos. No período de acompanhamento, com média de tempo de seguimento de 58,0 (±13,1) meses, ocorreram 142 óbitos (16,4%). Observou-se que para cada acréscimo no escore de capacidade intrínseca, ocorreu diminuição do risco de mortalidade em 21% (p<0,001). Conclusão A capacidade intrínseca exerceu papel preditivo sobre a mortalidade das pessoas idosas. Gerais Brasil domiciliar quantitativa país 58 5 8 5, ±1,63 163 1 63 (±1,63 pontos acompanhamento 580 0 58, ±13,1 131 13 (±13,1 meses 14 16,4%. 164 16,4% . 16 4 (16,4%) Observouse Observou se 21 p<0,001. p0001 p p<0,001 001 (p<0,001) ±1,6 6 (±1,6 ±13, (±13, 16,4 (16,4% 2 p000 p<0,00 00 (p<0,001 ±1, (±1, ±13 (±13 16, (16,4 p00 p<0,0 (p<0,00 ±1 (±1 (16, p0 p<0, (p<0,0 ± (± (16 p<0 (p<0, ( (1 p< (p<0 (p< (p

Resumo Objetivo: Este estudo avalia os efeitos da sarcopenia e da caquexia na qualidade de vida de pacientes com câncer gastrointestinal durante o ciclo inicial de quimioterapia, enfatizando a importância da tomografia computadorizada (TC) na avaliação da massa muscular. Materiais e Métodos: Estudo prospectivo com 60 pacientes adultos com câncer gastrointestinal que iniciaram quimioterapia de janeiro a dezembro de 2017. A TC foi utilizada para o diagnóstico de sarcopenia e o Quality of Life Questionnaire Core 30 da European Organization for Research and Treatment of Cancer foi utilizado para avaliar a qualidade de vida. Resultados: A média de idade dos pacientes foi 60,9 anos e 33 (55%) eram homens. Entre os pacientes, 33 (55%) eram caquéticos e 14 (24%) eram sarcopênicos. A quimioterapia reduziu significativamente a qualidade de vida, especialmente nos domínios físico, de desempenho de papéis e social, sem diferenças entre os grupos caquéticos e sarcopênicos. Conclusão: A diminuição da qualidade de vida não difere significativamente entre pacientes caquéticos/sarcopênicos e não caquéticos/não sarcopênicos com câncer gastrointestinal submetidos a quimioterapia, conforme classificado pela massa muscular medida por TC. No entanto, a avaliação da massa muscular por TC continua crucial para orientar estratégias de intervenção personalizadas. A integração dessa avaliação nos laudos radiológicos pode fornecer informações valiosas para o planejamento de cuidados específicos, melhorando a qualidade de vida dos pacientes durante o tratamento. Objetivo (TC Métodos 6 2017 3 Resultados 609 9 60, 55% 55 (55% homens 1 24% 24 (24% físico social Conclusão caquéticossarcopênicos caquéticosnão entanto personalizadas específicos tratamento 201 5 (55 2 (24 20 (5 (2 (

Abstract Objective: This study evaluates the effects of sarcopenia and cachexia on the quality of life (QoL) of patients with gastrointestinal cancer during their initial cycle of chemotherapy, emphasizing the significance of computed tomography (CT) in assessing muscle mass. Materials and Methods: In this prospective study, we evaluated 60 adult patients with gastrointestinal cancer who started chemotherapy between January and December of 2017. Sarcopenia was diagnosed on the basis of CT findings, and QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Results: The mean age was 60.9 years, and 33 (55.0%) of the patients were men. Of the 60 patients, 33 (55.0%) had cachexia and 14 (23.3%) had sarcopenia. Chemotherapy significantly reduced QoL, particularly in the physical, role functioning, and social domains, with no differences between the cachexia and sarcopenia groups. Conclusion: Among patients with gastrointestinal cancer submitted to chemotherapy, the chemotherapy-induced decline in QoL does not seem to differ significantly between those with cachexia or sarcopenia, as classified by CT-measured muscle mass, and those without. However, CT-based muscle mass evaluation remains crucial for guiding customized intervention strategies. Integrating this evaluation in radiological reports can provide valuable insights for planning specific care, thus improving patient QoL during treatment. Objective (QoL (CT Methods 6 2017 findings 30 Results 609 9 60. years 3 55.0% 550 55 0 (55.0% men 1 23.3% 233 23 (23.3% physical functioning domains groups Conclusion chemotherapyinduced induced CTmeasured measured without However CTbased based strategies care treatment 201 55.0 5 (55.0 23.3 2 (23.3 20 55. (55. 23. (23. (55 (23 (5 (2 (

Resumo Este artigo objetivou verificar a relação entre os fatores socioeconômicos e a pandemia da covid-19 nos municípios de médio porte mineiros. O procedimento de análise de dados foi a modelagem de equações estruturais de mínimos quadrados parciais. As variáveis utilizadas foram vulnerabilidade, saneamento, renda, agravantes, vacinação, casos de covid-19, mortalidade por covid-19, hospitalização e doenças crônicas não transmissíveis. Os dados foram coletados no Índice Mineiro de Responsabilidade Social, no painel de monitoramento dos casos de covid-19 e no painel de monitoramento de vacinação contra covid-19. O recorte temporal foi determinado pelo início da pandemia e a disponibilidade de dados (março de 2020 a setembro de 2021). Os resultados evidenciaram que melhores condições de saneamento estão negativamente relacionadas aos casos de covid-19, a renda está positivamente relacionada com os casos de covid-19 e a taxa de mortalidade por doenças crônicas não transmissíveis está relacionada de forma positiva com a mortalidade por covid-19. Os casos de covid-19 têm impacto negativo na hospitalização e a hospitalização tem impacto positivo na mortalidade. Os casos moderados pela vacinação estão negativamente relacionados à mortalidade por covid-19. Os resultados confirmam que condições socioeconômicas menos favoráveis tornam a sociedade mais vulnerável a covid-19.

Abstract This study investigated the correlation between socioeconomic factors and the COVID-19 pandemic in medium-sized Minas Gerais municipalities. Data were analyzed by partial least squares structural equation modeling, using the following variables: vulnerability, sanitation, income, aggravating factors, vaccination, COVID-19 cases, COVID-19 mortality, hospitalization and non-communicable chronic diseases. Data were obtained from the Minas Gerais Social Responsibility Index, the COVID-19 cases monitoring panel and the COVID-19 vaccination monitoring panel. Data collection time frame was determined by the onset of the pandemic and data availability (March 2020 to September 2021). Results showed that better sanitation conditions are negatively related to COVID-19 cases, income is positively related to COVID-19 cases, and higher mortality from chronic noncommunicable diseases are positively related to COVID-19 mortality. COVID-19 cases have a negative impact on hospitalization and hospitalization has a positive impact on mortality. Cases, moderated by vaccination, are negatively related to COVID-19 mortality. These findings confirm that less favorable socioeconomic conditions make society more vulnerable to COVID-19.

ABSTRACT BACKGROUND AND OBJECTIVES: Patient-controlled analgesia (PCA) is effective in controlling pain, but has numerous associated risks, such as: hypotension, respiratory depression, seizures and excessive sedation. The promotion of patient safety aims to reduce the risk of unnecessary health injuries and, therefore, it is important to analyze the failures and risk factors present throughout the process proactively. Therefore, the aim of this study was to map the available evidence on the risks of adverse events associated with the PCA technique and patient safety actions. CONTENTS: This is a scoping review conducted according to the JBI methodology, whose research question was based on the PCC strategy. The source of information is open and the search occurred in three stages. The databases used were: Medline/Pubmed; LILACS; CINAHL/ EBSCOhost; CENTRAL; Portal Capes; SCOPUS; Web of Science; Google academic; Brazilian Digital Library of Theses and Dissertations; Portal NICE; and Portal ISMP. The search strategy was divided into 3 stages: the first occurred in Medline and Cinahl to identify articles and index terms on the topic; the second used all keywords in all included databases; the third consisted of tracking searches in the reference lists of the included studies. The search resulted in 1,164 studies, of which 83 were selected based on the inclusion criteria: addressing the risks associated with the PCA pump or safety measures, hospital context, without restriction as to the type of study, language, and year. The studies are distributed in categories: previous diseases, profile of indications, types of opioids, types of pump and infusion, adverse effects, incidents without harm, stages of risk, and safety measures. CONCLUSION: This study made it possible to identify the risks of adverse events associated with the use of PCA in different stages and safety actions, demonstrating that when performed with appropriate patients, trained staff, safe devices, and correct prescription it provides a statistically significant improvement in pain relief, safely with advantages that conventional analgesia does not have. OBJECTIVES Patientcontrolled Patient controlled (PCA hypotension depression sedation therefore proactively Therefore actions CONTENTS methodology Medline/Pubmed MedlinePubmed Pubmed LILACS CINAHL EBSCOhost CENTRAL Capes SCOPUS Science academic Dissertations NICE ISMP topic 1164 1 164 1,16 8 criteria measures context language year categories diseases indications opioids infusion effects harm CONCLUSION patients staff devices relief have 116 16 1,1 11 1,

RESUMO JUSTIFICATIVA E OBJETIVOS: A analgesia controlada pelo paciente (ACP) é eficaz no controle da dor, porém apresenta inúmeros riscos associados, tais como: hipotensão arterial, depressão respiratória, convulsões e sedação excessiva. A promoção da segurança do paciente visa reduzir o risco de lesões desnecessárias à saúde e, para tanto, é importante analisar as falhas e fatores de risco presentes em todo o processo de forma proativa. Portanto, o objetivo deste estudo foi mapear as evidências disponíveis sobre os riscos de eventos adversos associados à técnica de ACP e a ações de segurança do paciente. CONTEÚDO: Trata-se de uma revisão de escopo realizada segundo a metodologia Joanna Briggs Institute para Scoping Reviews, cuja questão de pesquisa se baseou na estratégia PCC (P: população; C: conceito; C: contexto). As bases de dados utilizadas foram: Medline/Pubmed, LILACS, CINAHL/EBSCOhost, CENTRAL, Portal Capes, SCOPUS, Web of Science, Google acadêmico, Biblioteca Digital Brasileira de Teses e Dissertações, Portal NICE, Portal ISMP. A estratégia de busca foi dividida em 3 etapas: a primeira ocorreu na Medline e Cinahl para identificar artigos e termos de índice sobre o tema; a segunda utilizou todas as palavras-chaves em todas as bases de dados incluídas; a terceira consistiu no rastreamento de pesquisas nas listas de referências dos estudos incluídos. A busca resultou em 1.164 estudos, dos quais 83 foram selecionados com base nos seguintes critérios de inclusão: abordagem dos riscos associados à bomba de ACP ou a medidas de segurança, contexto hospitalar, sem restrição quanto ao tipo de estudo, idioma e ano. Os achados sintetizados estão distribuídos em categorias: doenças prévias, perfil das indicações, tipos de opioides, tipos de bomba e de infusão, efeitos adversos, incidentes sem lesões, estágios de risco e medidas de segurança. CONCLUSÃO: Este estudo possibilitou identificar os riscos de eventos adversos associados ao uso da ACP em diferentes estágios e ações de segurança, demonstrando que quando realizada com pacientes adequados, com equipe treinada, dispositivos seguros e prescrição correta, fornece uma melhora estatisticamente significativa no alívio da dor, de forma segura e com vantagens que a analgesia convencional não possui. OBJETIVOS (ACP dor como arterial respiratória excessiva tanto proativa Portanto CONTEÚDO Tratase Trata Reviews P (P população C conceito contexto. . contexto) MedlinePubmed Pubmed Medline/Pubmed LILACS CINAHLEBSCOhost CINAHL EBSCOhost CINAHL/EBSCOhost CENTRAL Capes SCOPUS Science acadêmico Dissertações NICE ISMP etapas tema palavraschaves palavras chaves incluídas incluídos 1164 1 164 1.16 8 inclusão hospitalar ano categorias prévias indicações opioides infusão CONCLUSÃO adequados treinada correta possui 116 16 1.1 11 1.

Abstract BACKGROUND: Obesity is a risk factor for falls in older adults, but the effects of body fat distribution and its interaction with other factors are not well established. OBJECTIVES: To verify the occurrence of falls among older adults with and without abdominal obesity and the effects of sociodemographic, health, and behavioral variables on this outcome. DESIGN AND SETTING: A cross-sectional study in an urban area of Alcobaça, Brazil. METHODS: Men and women older than 60 years with (270) and without (184) abdominal obesity were included. Sociodemographic, health, and behavioral data were collected using validated questionnaires in Brazil. Descriptive and path analyses were performed (P < 0.05). RESULTS: The occurrence of falls was high in participants with abdominal obesity (33.0%). In both groups, a higher number of morbidities (β = 0.25, P < 0.001; β = 0.26, P = 0.002) was directly associated with a higher occurrence of falls. Among participants without abdominal obesity, a lower number of medications (β = -0.16; P = 0.04), a higher number of depressive symptoms (β = 0.15; P = 0.04), worse performance on the agility and dynamic balance tests (β = 0.37; P < 0.001), and lower functional disability for basic activities of daily living (β = -0.21; P = 0.006) were directly associated with the occurrence of falls. CONCLUSION: Adults older than 60 years with abdominal obesity have a higher prevalence of falls. Different factors were associated with the occurrence of falls in both groups.

Abstract Sugammadex is a distinctive neuromuscular reversal drug that acts by encapsulating the neuromuscular relaxant molecule and dislodging it from its site of action. Sugammadex has been approved for pediatric patients over 2 years of age. Although arrhythmias have been reported, there is no report of adverse effects in healthy children, such as severe bradycardia requiring intervention. We report two cases of severe bradycardia immediately after the administration of sugammadex in healthy children. Our aim is to alert to the occurrence of one of the most severe adverse effects of sugammadex, in the healthy pediatric population as well. action age reported children intervention well

Abstract Tobacco-related diseases burden the entire public health system, at the three levels of governance: municipal, state and federal. The insertion of the theme of tobacco control in state and municipal Health Secretariats is historic, being present since the initial debates on the health, social, economic and environmental damage that smoking causes to the Brazilian population as a cycle of diseases, poverty and deaths precocious. This article aims to present the importance of articulating the National Tobacco Control Policy with the Councils of Municipal Health Secretariats, given the role that these instances play in the Unified Health System and the contributions that they can add to the Tobacco Control Policy in Brazil, with its constant challenges to advance in the reduction of deaths and illnesses caused by tobacco products. Tobaccorelated related system governance federal historic social precocious Brazil products

Resumo As doenças relacionadas ao tabaco sobrecarregam todo o sistema público de saúde, nos três níveis de governança: municipal, estadual e federal. A inserção do tema do controle de tabaco nas Secretarias de Saúde estaduais e municipais é histórica, estando presente desde os debates iniciais sobre os danos sanitários, sociais, econômicos e ambientais que o tabagismo gera à população brasileira como um ciclo de doenças, pobreza e mortes precoces. Este artigo tem como proposta apresentar a importância da articulação da Política Nacional de Controle do Tabaco com os Conselhos de Secretarias Municipais de Saúde, dado o papel que essas instâncias desempenham no Sistema Único de Saúde e as contribuições que poderão somar à Política de Controle de Tabaco no Brasil, com seus constantes desafios para avançar na redução de mortes e adoecimentos causados pelos produtos de tabaco. saúde governança municipal federal histórica sanitários sociais precoces Brasil

Abstract Introduction The consumption of tobacco products, from planting to consumption, is responsible for serious health problems, representing a cycle of diseases, poverty and deaths worldwide. This serious public health problem led Brazil to develop, from the 1980s onwards, a set of tobacco control measures, constituting a policy with legislative, economic, communication and educational actions, which has as its foundation the National Program for Control of Tobacco. Tobacco (PNCT). Objective This article is an experience report that is part of a national study carried out between 2020 and 2022, and describes actions through technical visits to tobacco control coordination offices in five states. Method The states were selected according to criteria established by Ditab/INCA, which coordinates the network of the State Program for Tobacco Control (PECT) in the 26 States and Federative Unit of the country. Thus, a State of each region was chosen: Tocantins (North), Paraíba (Northeast), Goiás (Midwest), Rio de Janeiro (Southeast) and Paraná (South). Results Practices were developed to enhance, improve and add technical, political, communication actions, among others, in order to give sustainability to the State Program and, more broadly, the PNCT. products problems diseases worldwide develop s onwards measures legislative economic PNCT . (PNCT) 202 2022 DitabINCA Ditab INCA Ditab/INCA PECT (PECT 2 country Thus chosen North, North , (North) Northeast, Northeast (Northeast) Midwest, Midwest (Midwest) Southeast (Southeast South. South (South) enhance political others broadly (PNCT 20 (North (Northeast (Midwest (South

Resumo Introdução: O consumo dos produtos derivados do tabaco, do plantio ao consumo, são responsáveis por graves problemas de saúde, representando um ciclo de doenças, pobreza e mortes em todo o mundo. Esse grave problema de saúde pública levou o Brasil a desenvolver, a partir da década de 80, um conjunto de medidas de controle do tabaco, constituindo uma política com ações legislativas, econômicas, de comunicação e educativas, que tem como alicerce o Programa Nacional de Controle do Tabaco (PNCT). Objetivo Este artigo é um relato de experiência que parte de um estudo nacional desenvolvido entre 2020 e 2022, e descreve atuação através de visitas técnicas junto às coordenações de controle do tabagismo de cinco estados. Método Os estados foram selecionados mediante a critérios estabelecidos pela Ditab/INCA, que coordena a rede do Programa Estadual de Controle do Tabagismo (PECT) nos 26 estados e Distrito Federal. Desta forma, foi escolhido um estado de cada região: Tocantins (Norte), Paraíba (Nordeste), Goiás (Centro-Oeste), Rio de Janeiro (Sudeste) e Paraná (Sul). Resultados Foi desenvolvido um conjunto de práticas que possam potencializar, aprimorar e agregar ações técnicas, políticas, de comunicação, dentre outras, de modo a dar sustentabilidade ao Programa Estadual e de maneira mais ampla, o PNCT. Introdução tabaco doenças mundo desenvolver 80 legislativas econômicas educativas PNCT . (PNCT) 202 2022 DitabINCA Ditab INCA Ditab/INCA PECT (PECT 2 Federal forma região Norte, Norte , (Norte) Nordeste, Nordeste (Nordeste) CentroOeste, CentroOeste Centro Oeste (Centro-Oeste) Sudeste (Sudeste Sul. Sul (Sul) potencializar políticas outras ampla 8 (PNCT 20 (Norte (Nordeste (Centro-Oeste (Sul